Literature DB >> 12211608

Expression of the filarial nematode phosphorylcholine-containing glycoprotein, ES62, is stage specific.

G Stepek1, M Auchie, R Tate, K Watson, D G Russell, E Devaney, W Harnett.   

Abstract

ES62, an immunomodulatory phosphorylcholine-containing glycoprotein secreted by the rodent filarial nematode Acanthocheilonema viteae, has previously been shown to be produced by L4 larvae and adult worms only. However, homologous sequences to ES62 have recently been found in L1 and L3 cDNA libraries of certain human filarial nematodes. Therefore, the various stages of A. viteae were re-examined and it was again found that only the post-L3 stages secreted ES62. Synthesis but not secretion by earlier stages was ruled out by examination of the protein content of whole worm extracts and by immunoelectron microscopy. However, examination by PCR of the mRNA for ES62 revealed that it was found in the L1 and L3 larvae. This may explain why homologous sequences to ES62 have been found in Brugia malayi and Onchocerca volvulus larval cDNA libraries. It also suggests that filarial nematodes, in general, may secrete ES62. To obtain evidence for this, we investigated production by Brugia pahangi, a close relation of B. malayi. We found that ES62 was indeed secreted but, as with A. viteae, only by the post-L3 stages, although again the mRNA for ES62 could be detected in the earlier stages. Overall our results suggest that production of ES62 is not species specific, that it is indeed stage specific, and that this may be due to post-transcriptional control of expression.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12211608     DOI: 10.1017/s0031182002001920

Source DB:  PubMed          Journal:  Parasitology        ISSN: 0031-1820            Impact factor:   3.234


  9 in total

Review 1.  Signalling mechanisms underlying subversion of the immune response by the filarial nematode secreted product ES-62.

Authors:  Helen S Goodridge; Gillian Stepek; William Harnett; Margaret M Harnett
Journal:  Immunology       Date:  2005-07       Impact factor: 7.397

Review 2.  The role of regulatory T cells in respiratory infections and allergy and asthma.

Authors:  Peter McGuirk; Sarah C Higgins; Kingston H G Mills
Journal:  Curr Allergy Asthma Rep       Date:  2010-01       Impact factor: 4.806

Review 3.  Microbial modulation of host immunity with the small molecule phosphorylcholine.

Authors:  Sarah E Clark; Jeffrey N Weiser
Journal:  Infect Immun       Date:  2012-12-10       Impact factor: 3.441

4.  Hyporesponsiveness of murine B lymphocytes exposed to the filarial nematode secreted product ES-62 in vivo.

Authors:  Emma H Wilson; Maureen R Deehan; Elad Katz; Kirsty S Brown; Katrina M Houston; John O'Grady; Margaret M Harnett; William Harnett
Journal:  Immunology       Date:  2003-06       Impact factor: 7.397

Review 5.  Parasite-Derived Proteins for the Treatment of Allergies and Autoimmune Diseases.

Authors:  Zhenyu Wu; Lifu Wang; Yanlai Tang; Xi Sun
Journal:  Front Microbiol       Date:  2017-11-07       Impact factor: 5.640

Review 6.  The Gut Microbiota in the Pathogenesis and Therapeutics of Inflammatory Bowel Disease.

Authors:  Tao Zuo; Siew C Ng
Journal:  Front Microbiol       Date:  2018-09-25       Impact factor: 5.640

Review 7.  How helminths use excretory secretory fractions to modulate dendritic cells.

Authors:  Rhiannon R White; Katerina Artavanis-Tsakonas
Journal:  Virulence       Date:  2012-11-15       Impact factor: 5.882

8.  Brugia malayi Antigen (BmA) Inhibits HIV-1 Trans-Infection but Neither BmA nor ES-62 Alter HIV-1 Infectivity of DC Induced CD4+ Th-Cells.

Authors:  Emily E I M Mouser; Georgios Pollakis; Maria Yazdanbakhsh; William Harnett; Esther C de Jong; William A Paxton
Journal:  PLoS One       Date:  2016-01-25       Impact factor: 3.240

9.  Development of Acanthocheilonema viteae in Meriones shawi: Absence of microfilariae and production of active ES-62.

Authors:  Felicity E Lumb; James Doonan; Marlene Corbet; Miguel A Pineda; Margaret M Harnett; William Harnett
Journal:  Parasite Immunol       Date:  2020-11-10       Impact factor: 2.280

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.